Marimed (MRMD) Change in Account Payables (2011 - 2026)

Marimed (MRMD) has reported Change in Account Payables for 16 consecutive years, with -$2.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Account Payables rose 29.9% year-over-year to -$2.0 million in Q2 2026; TTM through Jun 2026 was $2.1 million, a 199.2% increase from a year earlier, with the FY2025 full-year figure at $841000.0, down 79.92% from the prior year.
• Change in Account Payables was -$2.0 million for Q2 2026 at Marimed, down from $523000.0 in the prior quarter.
• Over five years, Change in Account Payables peaked at $3.5 million in Q4 2025 and troughed at -$2.8 million in Q2 2025.
• A 5-year average of $388444.4 and a median of $427500.0 in 2022 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables slumped 278.92% in 2022 and jumped 11134.38% in 2025, its largest moves.
• Over 5 years, Change in Account Payables stood at -$1.3 million in 2022, then jumped by 137.7% to $507000.0 in 2023, then plunged by 106.31% to -$32000.0 in 2024, then jumped by 11134.38% to $3.5 million in 2025, then slumped by 155.56% to -$2.0 million in 2026.
• The last three Change in Account Payables figures came in at -$2.0 million (Q2 2026), $523000.0 (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.